RNS Number : 7168P
GreenX Metals Limited
07 August 2026
 

Shape Description automatically generated with medium confidence

 

NEWS RELEASE | 7 August 2026

 

ISSUE OF SHARES

 

GreenX Metals Limited (GreenX or Company) advises that further to its announcement made on 4 August 2026, the Company has today issued 283,954 ordinary fully paid shares (Shares) in relation to the grant of an additional exploration licence at the Eleonore North Project.

An application will be made for the admission of 283,954 Shares to the Equity shares (international commercial companies secondary listing) listing segment of the Official List of the FCA (Official List) and to trading on the main market of the London Stock Exchange for listed securities (LSE Admission). Timing on LSE Admission will be disclosed once the application has been submitted.  

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules (DTRs), following LSE Admission, the Company's issued ordinary share capital will be 312,256,505 ordinary shares. The above figure of 312,256,505 may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following LSE Admission.

GreenX has the following securities on issue:

·      312,256,505 ordinary fully paid shares;

·      11,000,000 performance rights that have an expiry date 8 October 2026;

·      4,025,000 unlisted options exercisable at A$0.55 each on or before 30 November 2026;

·      7,600,000 unlisted options exercisable at A$1.05 each on or before 31 May 2029;

·      7,600,000 unlisted options exercisable at A$1.20 each on or before 31 May 2030; and

·      7,700,000 unlisted options exercisable at A$1.50 each on or before 31 May 2031.

 

Enquiries:

 

Ben Stoikovich

Chief Executive Officer

 

+44 207 478 3900

[email protected]

 

Kazimierz Chojna

Investor Relations - Poland

 

Kim Eckhof

Investor Relations - UK / Germany

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSASEWEMSEFA